Chronic Disease
Our work in Chronic Disease
-
Seminar Series – Jorge Luis Garcia
Jorge Luis Garcia, PhD, is an applied micro-economist working at the intersection of labor and development economics. His work aims to quantify the economic fundamentals underlying the causal effects of major policies to inform their design and evaluation.
-
Response to Sen. Cassidy’s Request for Information on Improving Americans’ Access to Gene Therapies
Schaeffer experts submitted a comment letter responding to a request for information from stakeholders about improving access to cell and gene therapies for ultra-rare diseases.
Categorized in -
Assessment of the U.S. Food and Drug Administration’s Risk Evaluation and Mitigation Strategy (REMS) for Prasugrel (EFFIENT): A Narrative Review
The prasugrel REMS consisted of passive educational materials whose adequacy was evaluated using highly limited, one-time, cross-sectional surveys. The study’s assessment adds to evidence suggesting the importance of improving the quality and impact of the FDA’s post-approval activities to maximize drug safety.
Categorized in -
Biden’s Hepatitis C Initiative Needs Help from the Private Market
Instead of this massive nationalized program, the White House could make four administrative changes that would jump-start private-sector solutions in each state.
Categorized in -
Seminar Series – Anup Malani
Anup Malani is a legal scholar and economist. He is the Lee & Brena Freeman Professor at the University of Chicago Law School and a Research Associate at the National Bureau of Economic Research.
-
Want Lower Obesity Drug Costs? Medicare Holds the Key
Medicare coverage will catalyze market competition
Categorized in -
Adherence and Persistence of HIV Pre-Exposure Prophylaxis Use in the United States
Adherence to daily PrEP is high among commercially insured individuals but the majority still discontinue in the first year.
Categorized in -
Comments in Response to a CBO Call for New Research on Obesity
While there are significant data and methodological challenges to be overcome, there are better alternatives to simplistically extrapolating from the real-world data on AOM use that is currently available.
Categorized in -
Seminar Series – Adriana Corredor-Waldron
Adriana Corredor-Waldron is an economist studying health disparities and mental health in the United States. She is an Assistant Professor of Economics at North Carolina State University.
-
Seminar Series – Lorens Helmchen
Lorens A. Helmchen, PhD, is an Associate Professor of Health Policy and Management in the Milken Institute School of Public Health at The George Washington University.